curaleaf
curaleaf · page 6
- Adult-Use
Business of Cannabis: New York Sessions
On December 9, 2021, Business of Cannabis launched our Business of Cannabis: New York Sessions series at The Williamsburg Hotel in Brooklyn.
- Uncategorized
A dive into the importance of social equity in emerging cannabis markets
In October, the cannabis industry reconvened in Las Vegas for the annual tradeshow – MJ Biz Con – put on by Marijuana Business Daily.
- Adult-Use
‘Science And Economics’ Will Forge A European Path To End Prohibition
SCIENCE and economics will win the day allowing cannabis to move from the illicit to legal-regulated markets across Europe, says the head of the world’s largest cannabis company.
- Adult-Use
Curaleaf on the fast track to growth
Wakefield, Massachusetts-based Curaleaf reported record earnings for Q1 this week at US$260 million, up 170% year over year.
- Medical
Curaleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC Move
FOLLOWING its recent acquisition of UK-firm EMMAC Life Sciences leading US player Curaleaf has wasted no time in expanding into Europe’s biggest medical cannabis market.
- Adult-Use
Curaleaf’s Recreational Cannabis Stores May Become A Feature Of Europe’s High Streets
EMMAC CEO Antonio Costanzo believes its purchase by US and global leader Curaleaf is a signal to Europe’s politicians that it is time to embrace the cannabis industry.
- Cultivation
The (Next) European Cannabis Invasion
America’s largest weed company, Curaleaf, is expanding into Europe with a $286 million cash-and-stock acquisition of London-based EMMAC Life Sciences, a medical cannabis cultivator operating in the UK, Germany, Portugal, Spain and Italy.
- Companies
Largest US Cannabis Retailer Buys Europe’s Largest Medical Cannabis Independent
SPECULATION EMMAC Life Sciences would be the next to float on the London Stock Exchange has been brought to a swift conclusion – with its purchase by leading US cannabis player Curaleaf Holdings.
